Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 9Myelodysplastic Syndromes 7Brain Neoplasms 7Neoplasm Metastasis 6Recurrence 5Glioma 5Glioblastoma 5Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Head and Neck Neoplasms 4Sarcoma 3Neoplasms 3Leukemia 3Colorectal Neoplasms 3Breast Neoplasms 3Astrocytoma 3Uveal Melanoma 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms, Neuroepithelial 2Nasopharyngeal Carcinoma 2Mouth Neoplasms 2Melanoma 2Diffuse Intrinsic Pontine Glioma 2Urologic Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Solid Tumor Malignancies 1

Interventions

Whole-Body Irradiation 6Peripheral Blood Stem Cell Transplantation 6Biopsy 6fludarabine phosphate 5Immunohistochemistry 5Epoetin Alfa 5Cyclophosphamide 5Tacrolimus 4Methotrexate 4Gene Expression Profiling 4Celecoxib 4Mycophenolic Acid 3Microarray Analysis 3Imiquimod 3Etoposide 3Darbepoetin alfa 3Cyclosporine 3Colposcopy 3Busulfan 3Antilymphocyte Serum 3Aminolevulinic Acid 3Tomography, Optical Coherence 2Sirolimus 2Polymerase Chain Reaction 2Methylprednisolone 2Melphalan 2Mass Spectrometry 2Immunoenzyme Techniques 2Filgrastim 2Fatty Acids, Omega-3 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Precancerous Conditions × Valproic Acid × Clear all
NCT00854581 2018-04-17

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

University of Miami

Phase 4 Terminated
13 enrolled 15 charts
LymphoidOther hematologic neoplasmOther neoplasm

Lymphoma, Precancerous Conditions, HTLV-I Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡